MarketCap
Facebook
X
TelegramAnnual report 2024
added 02-28-2026
ICON Public Limited Company Operating Expenses 2011-2026 | ICLR
Annual Operating Expenses ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 408 M | 398 M | 392 M | 385 M | 385 M | 384 M | 389 M | 360 M | 324 M | 295 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 408 M | 295 M | 372 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.99 B | $ 121.02 | 1.7 % | $ 36.8 B |  USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 2.96 | 4.71 % | $ 96.1 K | USA |
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 22.3 | -5.27 % | $ 234 M |  China |
 |
Celcuity
CELC
|
113 M | $ 111.31 | 3.64 % | $ 4.39 B | USA |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 28.14 | 2.07 % | $ 782 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 180.97 | 2.92 % | $ 8.97 B | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 14.14 | 2.56 % | $ 428 M | USA |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
106 M | $ 14.71 | -5.1 % | $ 1.91 B | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
IDEXX Laboratories
IDXX
|
1.3 B | $ 650.0 | 2.28 % | $ 52.3 B | USA |
 |
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | USA |
 |
Illumina
ILMN
|
3.69 B | $ 129.59 | 0.02 % | $ 20.6 B | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.14 | 1.88 % | $ 1.45 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 208.63 | 0.13 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 205.32 | 0.63 % | $ 146 B | USA |
 |
Organovo Holdings
ONVO
|
23.3 M | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | $ 103.51 | 0.13 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
217 M | $ 8.42 | -3.66 % | $ 527 M | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 9.65 | -6.26 % | $ 274 M | Israel |
 |
DexCom
DXCM
|
1.89 B | $ 73.39 | 0.42 % | $ 28.6 B | USA |
 |
PerkinElmer
PKI
|
1.07 B | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
11.3 M | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B |  Niderland |
 |
Quotient Limited
QTNT
|
106 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Renalytix AI plc
RNLX
|
29.8 M | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
411 M | $ 19.28 | 2.56 % | $ 1.03 B | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 281.11 | -0.69 % | $ 23.4 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 77.74 | -1.4 % | $ 5.25 B | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
226 M | $ 93.95 | 0.7 % | $ 11.8 B | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 177.49 | 2.0 % | $ 30.5 B | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 290.77 | -1.92 % | $ 26.6 B | Schweiz |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 12.53 | 8.11 % | $ 99.4 M | Israel |
 |
Co-Diagnostics
CODX
|
45.3 M | - | - | $ 79.8 M | USA |
 |
Myriad Genetics
MYGN
|
964 M | $ 5.35 | 1.04 % | $ 495 M | USA |